Full Text
Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil

Abstract

Authors

U. Majethia G. Tremblay L. Borges T. Jones A. Forsythe D. Pomerantz O.A.C. Clark

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×